Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Angelica Cardona

Starting Cyclosporine on Day Zero and Mycophenolate on Day + 1 in Unmanipulated Peripheral Blood Haplo Transplant With Cyclophosphamide Post-Transplantation Is Feasible, Abrogate the Severity of Cytokine Release Syndrome and Achieves a Very Low Rate of aGVHD

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2019

English

Related publications

Unrelated Cord Blood Transplantation and Post-Transplant Cyclophosphamide

Haematologica

Hematology

2018

English

Unmanipulated Haploidentical Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide in a Patient With Paroxysmal Nocturnal Hemoglobinuria and Secondary Aplastic Anemia

Bone Marrow Transplantation

Transplantation

Hematology

2015

English

Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-Sct) With Pre-Transplant Immunosuppression and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: A Novel Approach Transplant for Nonmalignant Diseases

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2015

English

Low Incidence of Chronic GVHD After HLA-haploidentical Peripheral Blood Stem Cell Transplantation With Post-Transplantation Cyclophosphamide in Older Patients

British Journal of Haematology

Hematology

2016

English

Outpatient-Based Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

Day Zero, Defeat Day Zero

Journal of the American Water Works Association

English

Peripheral Blood Progenitor Cell Mobilization in Patients With Multiple Myeloma Utilizing a Reduced Fixed Dose of Plerixafor and a Unique Mobilization Algorithm Is Feasible and Maximizes Day 1 Collection Yield

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Conversion of Liver Transplant Recipients on Cyclosporine With Renal Impairment to Mycophenolate Mofetil

Liver Transplantation and Surgery

1999

English

Impact of Class Ii Hla Mismatch on Clinical Outcomes in Hodgkin Lymphoma Patients Receiving Haploidentical Stem Cell Transplantation (Haplo-Sct) With Post-Transplant Cyclophosphamide (Pt-Cy)

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Angelica Cardona

Starting Cyclosporine on Day Zero and Mycophenolate on Day + 1 in Unmanipulated Peripheral Blood Haplo Transplant With Cyclophosphamide Post-Transplantation Is Feasible, Abrogate the Severity of Cytokine Release Syndrome and Achieves a Very Low Rate of aGVHD

Related publications

Unrelated Cord Blood Transplantation and Post-Transplant Cyclophosphamide

Unmanipulated Haploidentical Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide in a Patient With Paroxysmal Nocturnal Hemoglobinuria and Secondary Aplastic Anemia

Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-Sct) With Pre-Transplant Immunosuppression and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: A Novel Approach Transplant for Nonmalignant Diseases

Low Incidence of Chronic GVHD After HLA-haploidentical Peripheral Blood Stem Cell Transplantation With Post-Transplantation Cyclophosphamide in Older Patients

Outpatient-Based Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Day Zero, Defeat Day Zero

Peripheral Blood Progenitor Cell Mobilization in Patients With Multiple Myeloma Utilizing a Reduced Fixed Dose of Plerixafor and a Unique Mobilization Algorithm Is Feasible and Maximizes Day 1 Collection Yield

Conversion of Liver Transplant Recipients on Cyclosporine With Renal Impairment to Mycophenolate Mofetil

Impact of Class Ii Hla Mismatch on Clinical Outcomes in Hodgkin Lymphoma Patients Receiving Haploidentical Stem Cell Transplantation (Haplo-Sct) With Post-Transplant Cyclophosphamide (Pt-Cy)